Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Credit agrmnt [a]
Appointed CFO
Quarterly results
Director departure
CC transcript

Anika Therapeutics, Inc. (ANIK) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Nunes Anne (SVP, Chief Operations Officer) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 732 shares @ $18.63, valued at $13.6k
Exercised 2,491 restricted stock units @ $0
08/11/2023 4 Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,133 shares @ $18.58, valued at $21.1k
Exercised 3,859 restricted stock units @ $0
06/16/2023 4 VOGT SUSAN L N (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 6,500 shares @ $0
06/16/2023 4 Thompson Jeffery S (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 6,500 shares @ $0
06/16/2023 4 Richard Stephen (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 6,500 shares @ $0
06/16/2023 4 Larsen Glenn R. (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 6,500 shares @ $0
06/16/2023 4 HENNEMAN JOHN B III (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 6,500 shares @ $0
06/16/2023 4 Fischetti Gary P (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 6,500 shares @ $0
06/16/2023 4 CONLEY SHERYL L (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 6,500 shares @ $0
04/28/2023 4 Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 10,900 shares @ $26.34, valued at $287.1k
Exercised 24,575 restricted stock units @ $0
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2023 4 Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 2,609 shares @ $26.1, valued at $68.1k
Exercised 8,888 restricted stock units @ $0
03/14/2023 4 Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 2,250 shares @ $26.1, valued at $58.7k
Exercised 7,663 restricted stock units @ $0
03/14/2023 4 Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 13,211 shares @ $26.1, valued at $344.8k
Exercised 30,060 restricted stock units @ $0
03/10/2023 4 Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,303 shares @ $26.91, valued at $35.1k
Granted 17,624 restricted stock units @ $0
Granted 38,475 options to buy @ $0
Exercised 4,439 restricted stock units @ $0
03/10/2023 4 Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,081 shares @ $26.91, valued at $29.1k
Granted 16,395 restricted stock units @ $0
Granted 35,790 options to buy @ $0
Exercised 3,683 restricted stock units @ $0
03/10/2023 4 Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 4,232 shares @ $26.91, valued at $113.9k
Granted 60,004 restricted stock units @ $0
Granted 130,998 options to buy @ $0
Exercised 14,419 restricted stock units @ $0
03/07/2023 4 Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Paid exercise price by delivering 734 shares @ $31.59, valued at $23.2k
Exercised 2,500 restricted stock units @ $0
08/11/2022 4 Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Exercised 3,859 restricted stock units @ $0
06/10/2022 4 VOGT SUSAN L N (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 7,954 shares @ $0
06/10/2022 4 Richard Stephen (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 7,954 shares @ $0
06/10/2022 4 Larsen Glenn R. (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 7,954 shares @ $0
06/10/2022 4 HENNEMAN JOHN B III (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 7,954 shares @ $0
06/10/2022 4 CONLEY SHERYL L (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 7,954 shares @ $0
06/10/2022 4 Thompson Jeffery S (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 7,954 shares @ $0
05/12/2022 4 Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Bought 1,500 shares @ $21.37, valued at $32.1k
03/16/2022 4 Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Bought 1,500 shares @ $26.652, valued at $40k
03/15/2022 4 Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 22,988 restricted stock units @ $0
Granted 35,864 options to buy @ $0
03/15/2022 4 Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 26,664 restricted stock units @ $0
Granted 38,979 options to buy @ $0
03/15/2022 4 Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Granted 90,179 restricted stock units @ $0
Granted 208,821 options to buy @ $0
03/15/2022 4 Thompson Jeffery S (Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Bought 2,000 shares @ $24.659, valued at $49.3k
03/14/2022 4 Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Bought 4,287 shares @ $25.359, valued at $108.7k
Bought 3,813 shares @ $25.814, valued at $98.4k
03/14/2022 4 Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Bought 4,000 shares @ $24.619, valued at $98.5k
03/11/2022 4 Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.
Txns: Exercised 4,438 shares @ $0
Granted 4,438 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy